1st Topical JAK Inhibitor Up for MHLW Panel Review Oct. 25, Ono’s Cachexia Drug Still Shelved

Japan’s first topical JAK inhibitor will come up for discussion by a key health ministry advisory committee on October 25, pointing to its official approval as early as January, if all goes well. Meanwhile, Ono Pharmaceutical’s cancer cachexia treatment anamorelin,...read more